EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bile acids inhibit equilibrative adenosine transport to alter adenosine receptor signaling in cholestasis

Arnav Joshi, Sijie Chen, Fazlur Md Rahman, Sreenath Nair, Xiaolin Cheng, Rajgopal Govindarajan

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.108563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Arnav Joshi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Cholestasis, Bile Acids and Salts, Signal Transduction, Adenosine. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High plasma bile acid (BA) levels in individuals with cholestasis affect adenosine (Ado) receptor (AdoR) signaling, but the underlying mechanisms are unclear. Here, we investigated BA interference with cellular Ado transport as a putative mechanism for altering extracellular Ado availability for AdoR signaling. Computational modeling and experimental studies revealed that equilibrative nucleoside transporter 2 (ENT2), but not ENT1, is capable of translocating BAs across the mammalian plasma membrane. ENT2-mediated BA transport has low affinity, is pH independent, and is partially sensitive to inhibition by nitrobenzylthioinosine (NBMPR). At cholestatic plasma concentrations of BAs, however, BAs interfere with Na+-independent, NBMPR-sensitive, ENTs without affecting Na+-driven, NBMPR-insensitive, concentrative nucleoside transporters. Interestingly, this BA interference with ENT transport was largely selective for Ado, with minimal to no impact on the transport of other purine or pyrimidine nucleosides. Xenopus oocyte-based studies demonstrated that BA inhibition of Ado transport is in the order ENT3≥ENT2>ENT1, which also corresponds to the intrinsic ability of individual ENTs to transport BAs. In silico analysis revealed that Ado and BA tend to occupy similar spaces within the ENT translocation pores and that the polar and hydrophilic pore-lining residues determine the interaction of ENTs with BAs. Furthermore, in vivo studies indicated that the accumulation of extraneously administered Ado decreases in the livers of cholestatic mice and that interference with Ado transport alters AdoR signaling. Together, these findings reveal novel ENT-dependent BA‒Ado interactions that may have implications for BA dysregulation of AdoR signaling in cholestatic liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholestasisBile Acids and SaltsSignal TransductionAdenosineEquilibrative-Nucleoside Transporter 2AnimalsHumansMiceBiological TransportXenopus laevisEquilibrative Nucleoside Transporter 1ThioinosineMale

Stichwörter der Autor:innen

adenosineadenosine receptorbile acidcholestasischolic acidequilibrativemodelingnucleosidesignalingtransporter

Substanzen

Bile Acids and SaltsAdenosineEquilibrative-Nucleoside Transporter 24-nitrobenzylthioinosineEquilibrative Nucleoside Transporter 1Thioinosine

Autor:innen und Institutionen

  • Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
  • Division of Medicinal Chemistry & Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
  • Division of Medicinal Chemistry & Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA; Translational Therapeutics, Ohio State University Comprehensive Cancer Center, Ohio State University,…
  • Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA; Translational Therapeutics, Ohio State University Comprehensive Cancer Center, Ohio State University, Columb…

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Joshi, A., Chen, S., Rahman, F. M., Nair, S., Cheng, X., & Govindarajan, R. (2025). Bile acids inhibit equilibrative adenosine transport to alter adenosine receptor signaling in cholestasis. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108563

Vancouver

Joshi A, Chen S, Rahman FM, Nair S, Cheng X, Govindarajan R. Bile acids inhibit equilibrative adenosine transport to alter adenosine receptor signaling in cholestasis. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108563

BibTeX
@article{Joshi2025,
  author = {Joshi, Arnav and Chen, Sijie and Rahman, Fazlur Md and Nair, Sreenath and Cheng, Xiaolin and Govindarajan, Rajgopal},
  title = {Bile acids inhibit equilibrative adenosine transport to alter adenosine receptor signaling in cholestasis},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.108563}
}
Kostenlos starten →